Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- We found the 12 go-to bankers for digital health companies and got their predictions for the industry;
- How fertility startup Kindbody is branching out beyond going directly to consumers;
- $5 billion digital health startup Ro is on a dealmaking spree.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
We found the 12 go-to digital health bankers. They broke down how tech is driving record deals and the next generation of giants.
- The digital-health sector is one of the hottest, with record M&A, go-publics, and private funding.
- We spoke with top bankers to understand what's driving deals and the next generation of giants.
- They said companies were harnessing tech and investor appetite to change in a few key ways.
The CEO of Kindbody shares how the $612 million fertility startup branched out beyond direct-to-consumer to work with major employers
- Kindbody just raised $62 million, valuing the "SoulCycle" of fertility clinics at $612 million.
- Over 1,000 patients have frozen their eggs or done other fertility treatments with the startup.
CEO Gina Bartasi said rising demand and the employer business are key to Kindbody's growth>>
$5 billion digital-health startup Ro is on a deal spree as competition heats up in the hottest part of healthcare
- Digital health startup Ro is acquiring at-home testing startup Kit.
- It's the company's third deal in the last year.
- The acquisitions are part of a digital health takeover boom as companies look to sustain growth.
More stories we're reading:
- The highly infectious Delta variant may already be dominant in the US, says leading coronavirus test lab (Insider)
- Fauci: The spread of the Delta variant threatens to widen the divide between parts of the US with high and low vaccination rates (CNN)
- Mutiny at Great Jones: How a cofounder war led every employee to quit Instagram's trendiest cookware company (Insider)
- Why it's hard to know if the Delta variant is deadlier (The Atlantic)
- Lydia
Read the original article on Business Insider